U.S. Markets open in 9 hrs 5 mins

An Update on JNJ’s Neuroscience Business after Q1 2018

Daniel Collins
An Update on JNJ’s Neuroscience Business after Q1 2018

In the first quarter, Johnson & Johnson’s (JNJ) Neuroscience business reported revenues of $1.6 billion compared to $1.5 billion in the first quarter of 2017, which reflected ~4.1% YoY (year-over-year) growth.